NASDAQ: ABVC - ABVC BioPharma, Inc.

छह महीने के लिए लाभप्रदता: -22.82%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम ABVC BioPharma, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में ABVC BioPharma, Inc.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.

अधिक जानकारी
The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2017-10-11
ISIN US00091F1066
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.abvcpharma.com
Цена ао 1.28
प्रति दिन मूल्य परिवर्तन: +3.97% (0.559)
प्रति सप्ताह मूल्य परिवर्तन: +10.92% (0.524)
प्रति माह मूल्य परिवर्तन: +13.92% (0.5102)
3 महीने में कीमत में बदलाव: -15.44% (0.6873)
छह महीने में कीमत में बदलाव: -22.82% (0.753)
प्रति वर्ष मूल्य परिवर्तन: -49.9% (1.16)
3 वर्षों में मूल्य परिवर्तन: -83.86% (3.6)
5 वर्षों में मूल्य परिवर्तन: -93.54% (9)
10 वर्षों में मूल्य परिवर्तन: 0% (0.5812)
वर्ष की शुरुआत से मूल्य परिवर्तन: +8.64% (0.535)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 34.42 1
P/BV 0.6113 10
P/E 0 0
EV/EBITDA -0.8525 0
कुल: 4.25

क्षमता

नाम अर्थ श्रेणी
ROA, % -70.37 0
ROE, % -118.96 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.2994 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -78.29 0
लाभप्रदता Ebitda, % 146.44 10
लाभप्रदता EPS, % 7.8 1
कुल: 5.2
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Renaissance Technologies, LLC 36100 0.34
Vanguard Group Inc 27247 0.26
Citadel Advisors Llc 27158 0.26
Geode Capital Management, LLC 19480 0.18
Tower Research Capital LLC (TRC) 578 0.01
Spotlight Asset Group, Inc. 100 0
Royal Bank of Canada 37 0
Wells Fargo & Company 20 0



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Eugene Jiang Chairman & Chief Business Officer 200k 1986 (39 साल)
Dr. Tsung-Shann Jiang EMBA, Ph.D. Chief Scientific Officer, Chief Strategy Officer & Director 200k 1954 (71 वर्ष)
Dr. Uttam Yashwant Patil Ph.D. CEO & Interim CFO N/A 1986 (39 साल)

पता: United States, Fremont. CA, 44370 Old Warm Springs Boulevard - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.abvcpharma.com